[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_18200 

# __Lack of coronavirus vaccine__

## Articles mentionning the risk

* [Mehtab_alam_role_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_647.md)

## Mitigations of this risk

* [Accelerate vaccine development, conduct rigorous testing, and distribute the vaccine widely](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_20166.md)

## Name of the risk

Continued spread and impact of the coronavirus pandemic

## People affected by this risk

* [Global population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_278.md)

## Stakeholders who can mitigate this risk

* [Governments](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_47.md)
* [International health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2727.md)
* [Scientific research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_6404.md)

## Technologies linked to the risk

* [Clinical trial technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_5481.md)
* [Distribution and logistics technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_20518.md)
* [Vaccine development technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_20519.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

